Transdiagnostic Group Treatments for Patients With Common Mental Disorders in Primary Health Care
NCT ID: NCT01565213
Last Updated: 2012-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
245 participants
INTERVENTIONAL
2006-01-31
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Transdiagnostic Course for Common Mental Health Problems in Primary Care
NCT04522713
Transdiagnostic Online CBT Vs. Care As Usual for Primary Care Patients with Common Mental Disorders
NCT06804941
Integrating Motivational Interviewing With Cognitive-behavioral Therapy
NCT04254120
Trans-diagnostic Short-term Psychotherapy for Psychiatric Inpatients
NCT04704973
CBT Versus a Return to Work Intervention for Patients With Common Mental Illness in Primary Care
NCT01636791
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Clinical randomised non blinded controlled trial.
Setting:
The study was performed in an outpatient primary health care centre serving 36 000 inhabitants.
Participants:
Patients (n=278), aged 18-65 years, with common mental problems or disorders were referred to the study by the GPs and 245 were included in the study.
Interventions:
Participants were randomised to CAU or one of two group interventions in addition to CAU. These were: a) group cognitive behavioural based therapy (CBT) administered by psychologists once a week for 12 weeks, and b) group multimodal intervention (MMI) based on a protocol comprising a mix of existing group interventions and exercises borrowed from multiple techniques and therapeutic schools and administered by assistant nurses with brief training, including two sessions per week for 6 weeks.
Main outcome measures:
Primary outcome measure was the Mental Component Summary score of SF-36. Secondary outcome measures were perceived stress scale (PSS) and Self-Rating Scale for Affective Syndromes (CPRS-S-A)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CBT cognitive behavioral therapy
group cognitive behavioural based therapy (CBT) administered by psychologists once a week for 12 weeks
CBT
group cognitive behavioural based therapy (CBT) administered by psychologists once a week for 12 weeks,
MMI Multimodal group intervention
group multimodal intervention
MMI
group multimodal intervention (MMI) based on a protocol comprising a mix of existing group interventions and exercises borrowed from multiple techniques and therapeutic schools and administered by assistant nurses with brief training, including two sessions per week for 6 weeks.
CAU
Care as usual given by the GPs
CAU
Care as usual by the GPs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CBT
group cognitive behavioural based therapy (CBT) administered by psychologists once a week for 12 weeks,
MMI
group multimodal intervention (MMI) based on a protocol comprising a mix of existing group interventions and exercises borrowed from multiple techniques and therapeutic schools and administered by assistant nurses with brief training, including two sessions per week for 6 weeks.
CAU
Care as usual by the GPs
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* they met diagnostic criteria for bipolar or psychotic disorder or severe personality disorder,
* were judged to be at risk of committing suicidal acts, and
* if they had undergone MMI earlier. The investigators paid no consideration to whether patients were treated with SSRI medication.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kersti Ejeby
MD Head GP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Family and Community Medicine, Karolinska Institutet,
Huddinge, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LS 0506-1010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.